Anti-Breast Cancer Compound Library
Ref. TM-L2191
1mg | To inquire | |
30µl*10 (DMSO) | To inquire | |
50µl*10 (DMSO) | To inquire | |
100µl*10 (DMSO) | To inquire | |
250µl*10 (DMSO) | To inquire |
Product Information
A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study;
- Targets include HER-2, VEGF, EGFR, PARP, CDK4/6, HSP, PD-1, SET7/9, BRCA, etc.;
- Some compounds have been in market or in clinical trials;
- Detailed compound information with structure, target, and biological activity description;
- NMR and HPLC validated to ensure high purity and quality.
Chemical properties
Technical inquiry about: TM-L2191 Anti-Breast Cancer Compound Library
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.